Goldobenko G V, Durnov L A, Lobanov G V, Liutova N A, Belkina B M
Med Radiol (Mosk). 1985 Dec;30(12):3-7.
The results of multimodality therapy of 50 children with uni- or bilateral retinoblastoma were assessed. Gamma-beam therapy with the application of a special protective collimator and polychemotherapy were used as modalities supplementing eye extirpation. Some patients were irradiated prior to operation, the others following it. Despite a slight decrease in a tumor radiation dose in the first group, 2-year survival rates in both groups were the same. Of 32 patients 30 (94%) in both groups have been alive for 2 yrs. without signs of disease after multimodality therapy. Patients with Stage I retinoblastoma were subjected to chemo- and radiotherapy; 16 out of 18 patients have been alive for 2 yrs. It has been stressed that radiation therapy is an important component in multimodality therapy. It can be used as a modality of the combined method of tumor surgical removal or as a method of radical therapy in early forms of the disease.
对50例单侧或双侧视网膜母细胞瘤患儿的多模态治疗结果进行了评估。采用特殊防护准直器的伽马射线治疗和多药化疗作为眼球摘除术的辅助治疗手段。部分患者在手术前接受放疗,其余患者在手术后接受放疗。尽管第一组患者的肿瘤辐射剂量略有降低,但两组的2年生存率相同。两组32例患者中有30例(94%)在多模态治疗后存活2年且无疾病迹象。I期视网膜母细胞瘤患者接受了化疗和放疗;18例患者中有16例存活2年。强调放疗是多模态治疗的重要组成部分。它可作为肿瘤手术切除联合方法的一种手段,或作为疾病早期的根治性治疗方法。